OpportunityTitle: New Directions in Hematology Research (SHINE-II) (R01)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Description: This research Funding Opportunity Announcement (FOA), New Directions in Hematology Research (SHINE-II), is intended to promote innovative research initiatives that explore high impact, new directions of inquiry relevant to the hematology research mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This new Funding Opportunity builds upon the objectives of an on-going program defined by PAS-10-046: Stimulating Hematology Investigation: New Endeavors (or SHINE). With the SHINE-II program, NIDDK invites investigator-initiated grant applications for pre-clinical, proof of principle research projects that are tightly focused and directed at validating novel concepts and approaches that promise to open up new pathways for discovery. Research applications submitted under this FOA should be more limited in scope (a single central aim) and duration (1-3 years) than typical R01 grant applications.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster &lt;br/&gt;FBOWebmaster@OD.NIH.GOV &lt;br/&gt;